Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS).
Kerri BecktellYan ChenYutaka YasuiRachel PhelanGregory T ArmstrongMichael LinkKevin OeffingerClaire SnyderNajat DawBrent WeilChristopher B WeldonEric J ChowCindy L SchwartzPublished in: Pediatric blood & cancer (2024)
Contemporary osteosarcoma therapy with MAP plus LS, while improving 5-year disease-free survival, continues to be associated with a high burden of late mortality, CHCs, and health status limitations.